MARKSANSMarksans Pharma Ltd.

    Marksans Pharma Ltd: results and news

    Every Marksans Pharma Ltd filing with the NSE and BSE that Blacklitt has written about, explained in plain words and linked to the filing, newest first: earnings.

    1 article · pharmaceuticals · Latest 4 Nov 2026

    A dark wooden apothecary cabinet with small drawers and shelves holding white and blue glass medicine bottles, in a museum display.

    MARKSANSMarksans Pharma Ltd.

    Marksans Pharma Q2 FY27 Results: Consolidated Net Profit ₹144 Crore on Total Income of ₹958 Crore

    Marksans Pharma (NSE: MARKSANS) reported consolidated total income of ₹958.32 crore and consolidated net profit of ₹143.53 crore for the quarter ended 30 Sep 2026, it said in a filing on 04 Nov 2026. Standalone total income was ₹371.05 crore and standalone net profit was ₹85.54 crore for the same quarter.

    • Earnings
    • pharmaceuticals

    Blacklitt Research3 min read